Eloxx Pharmaceuticals Inc

NASDAQ:ELOX   3:59:41 PM EDT
1.68
-0.10 (-5.62%)
5:16:34 PM EDT: $1.46 -0.22 (-13.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Eloxx Pharmaceuticals Inc Stock, NASDAQ:ELOX

950 Winter Street, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.577.5300
Number of Employees: 25

Description

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA.